11:48 AM EST - Endo International plc : Announced that its pharmaceutical arm came out with new data to be presented, evaluating the safety and efficacy of XIAFLEX®(collagenase clostridium histolyticum) (or CCH) injection under investigation for the treatment of palmar Dupuytren's disease nodules. Endo International plc
shares T.ENL are trading down $0.95 at $26.75.
